Explore 3 Stock Ideas & Industry Insights Download Free Report

blue-chip

One Food & Drug Retailer Stock Under “Watch” Zone: Ocado Group PLC

May 06, 2020 | Team Kalkine
One Food & Drug Retailer Stock Under “Watch” Zone: Ocado Group PLC

 



Ocado Group PLC - Facing Unprecedented Challenges, With the Small Suppliers

United Kingdom-based Ocado Group Plc (LON: OCDO) is an online grocery retailer company. It develops end to end operating solutions, using its technology for online grocery retail. The company’s objective is to transmute online grocery via automation and cutting-edge technology.

On 14th July 2020, the company will release its interim results.

Update (as on 6th May 2020) – Representing Business Response to COVID-19 and Current Update
Throughout the continuing Coronavirus crisis, Ocado Retail has shown great resilience. At the start of the COVID-19 outbreak, demand improved significantly, almost overnight. During the unprecedented crisis, the company is also recognising the exceptional contribution of the front-line colleagues by giving them a bonus of 10 per cent. In the Second Quarter to date, the retail revenue increased by 40.4% as compared with the previous quarter (Q1 FY20: growth of 10.3%). Currently, the company is processing 110 thousand standard sized orders per week against the first quarter of 2020. During the period, the group has attained a milestone, with the delivery of the first international CFCs (customer fulfilment centres) to the international partners Sobeys and Groupe Casino. Overall, the company maintains decent liquidity and position with cash of £1.2 billion.

Share Price Performance

Daily Chart as at May-06-20, before the market closed (Source: Refinitiv, Thomson Reuters)

Ocado Group PLC’s shares were trading at GBX 1,732 before the market close (at 10:47 AM GMT+1) on 6th May 2020 and were up by 3.1% versus the previous day closing price. Stock 52 weeks High and Low are GBX 1,751.50 /GBX 994.01.

Valuation Metrics

(Source: LSE)

As on 31st March 2020, the Price to Sales multiple of the OCDO was 4.8x, which was higher as compared with the Food & Drug Retailers industry average of 0.4x. It indicates that the company is trading at a higher multiple as compared to its peers.

Key Risks
The company’s business is facing some uncertainties, which could affect the performance of the company. Brexit could also hamper the supply chain of the company, affecting the operations of the company. Some more risks: a technological disruption could affect the company’s overall performance; failure of engineering capabilities to be able to execute its business could hamper the revenue and profitability of the company; Failure of food safety or product safety could degrade the reputation of the company; any change in regulations or policies could impact the company’s revenue and costs.

Conclusion
The group continue to target further Solutions deals which would generate further cash fees but would negatively impact short term profits.Therefore, the company has suspended the outlook for Retail Revenue for FY2020 until OCDO can accurately estimate. In the financial year 2019, the company has made significant progress and signed up with three major supermarkets across three geographies, including a JV with M&S in the UK, entered into an agreement with Australia-based Coles to develop two CFCs. Currently, uncertainty persists over the lockdown scenario. Presently, the company is trading near the 52-week high, raising doubts at its upside potential at the current price level.

Based on the factors as highlighted above, we recommend investors to keep a “Watch” on the stock at the current price of GBX 1,751.50 (as on 6th May 2020, before the market close at 10:10 AM GMT+1), with support from few catalysts needs to be evaluated at a later stage.


Disclaimer

PLEASE BE ADVISED THAT YOUR CONTINUED USE OF THIS SITE OR THE INFORMATION PROVIDED HEREIN SHALL INDICATE YOUR CONSENT AND AGREEMENT TO THESE TERMS.
References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.
This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332.
The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine is not responsible for material posted on this website and does not guarantee the content, accuracy, or use of the content in this site. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated.
Kalkine do not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not in any way endorse or recommend individuals, products or services that may be discussed on this site. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional licensed financial planner and adviser.

Past performance is not a reliable indicator of future performance.

Support

Hi! How can we help you today?

Loading…